Harbor Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
65,730
+564
+0.9% +$13K 0.11% 260
2026
Q1
$1.56M Sell
65,166
-38,595
-37% -$943K 0.13% 242
2025
Q4
$2.35M Sell
103,761
-49,302
-32% -$1.07M 0.18% 147
2025
Q3
$3.08M Sell
153,063
-618,999
-80% -$10.4M 0.24% 89
2025
Q2
$11M Sell
772,062
-124,092
-14% -$1.45M 0.46% 48
2025
Q1
$9.41M Sell
896,154
-188,475
-17% -$2.13M 0.43% 54
2024
Q4
$13.1M Buy
1,084,629
+209,734
+24% +$2.74M 0.57% 35
2024
Q3
$12.9M Buy
874,895
+439,757
+101% +$6.13M 0.56% 34
2024
Q2
$6.28M Buy
435,138
+322,825
+287% +$5.16M 0.48% 36
2024
Q1
$1.83M Buy
+112,313
New +$1.76M 0.24% 96

Other funds holding ELAN

Harbor Capital Advisors's ELAN Position: Q2 2026 in Review

Harbor Capital Advisors increased its Elanco Animal Health (ELAN) stake by 0.87% in Q2 2026, buying an estimated $13K and bringing the position to 65,730 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #260.

Harbor Capital Advisors first reported a position in ELAN in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.1M in Q4 2024. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Harbor Capital Advisors held 65,730 shares of Elanco Animal Health worth $1.62M as of Q2 2026.
  • Harbor Capital Advisors bought 564 Elanco Animal Health shares in Q2 2026, an estimated $13K.
  • Elanco Animal Health made up 0.11% of Harbor Capital Advisors's portfolio in Q2 2026, its #260 holding.
  • Harbor Capital Advisors first reported a position in Elanco Animal Health in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Elanco Animal Health position peaked at $13.1M in Q4 2024.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.